Key result
High frailty was associated with an elevated risk of 90-day readmission (OR 1.27) and in-hospital mortality (OR 3.83) after minimally invasive colorectal cancer surgery.
Why the study?
Does higher frailty risk predict adverse postoperative outcomes and 90-day readmission in older patients undergoing minimally invasive CRC surgery?
Cohort (n=6,417)
Yes
Does higher frailty risk predict adverse postoperative outcomes and 90-day readmission in older patients undergoing minimally invasive CRC surgery?
Odds Ratio: 1.27
Higher frailty risk strongly predicts in-hospital mortality, complications, and 90-day readmission following minimally invasive colorectal cancer surgery in older adults.
Supports frailty screening before minimally invasive CRC surgery; leaves open whether modification improves outcomes.
BACKGROUND Minimally invasive procedures are common in colorectal cancer (CRC) surgeries, but the impact of frailty on postoperative outcomes is unclear. OBJECTIVE This study aimed to assess how frailty status affects postoperative outcomes after minimally invasive CRC surgery. METHODS This study examined the impact of frailty on postoperative outcomes following minimally invasive colorectal cancer (CRC) surgery. Using data from the 2016–2020 U.S. National Readmission Database, the study analyzed patients aged ≥60 who underwent minimally invasive surgery for CRC. Patients were categorized into low, intermediate, and high frailty risk groups based on the Hospital Frailty Risk Score (HFRS). Outcomes assessed included 90-day readmissions, in-hospital mortality, and complications. RESULTS The analysis of 6,417 patients revealed that intermediate frailty was associated with higher in-hospital mortality (OR = 2.01), and high frailty had an even greater risk (OR = 3.83). Frailty also showed a dose-response relationship with complications, with the odds of complications being significantly higher in both intermediate (OR = 4.59) and high frailty groups (OR = 37.12). Only the high frailty group had an elevated risk of 90-day readmission (OR = 1.27). Certain subgroups, such as patients aged <80, without diabetes or chronic kidney disease, with rectal tumors, and those undergoing robotic surgery, were particularly affected by frailty in terms of in-hospital mortality. CONCLUSIONS The study highlights that higher frailty, as measured by the HFRS, is a strong predictor of adverse postoperative outcomes and early readmission in older patients undergoing minimally invasive CRC surgery, with especially notable effects in certain subgroups.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) conducted a cohort in Colorectal cancer (n=6,417). High frailty (Hospital Frailty Risk Score) vs. Low frailty was evaluated on 90-day readmission (OR 1.27). High frailty was associated with an elevated risk of 90-day readmission (OR 1.27) and in-hospital mortality (OR 3.83) after minimally invasive colorectal cancer surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: